When quality of life is the major challenge.
Odile
O
Oberlin
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002170:Canada; D017024:Chemotherapy, Adjuvant; D002648:Child; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage; D005060:Europe; D006689:Hodgkin Disease / Q000188:drug therapy / Q000523:psychology* / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D008727:Methotrexate